aflibercept
Showing 51 - 75 of 125
Wet Macular Degeneration Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)
Diabetic Retinopathy Trial in Cleveland (Aflibercept, Sham)
Completed
- Diabetic Retinopathy
- Aflibercept
- Sham
-
Cleveland, OhioCole Eye Institute, Cleveland Clinic
May 12, 2020
Inflammatory Choroidal Neovascularization Trial in Lyon (Aflibercept)
Completed
- Inflammatory Choroidal Neovascularization
- Aflibercept
-
Lyon, FranceHospices Civils de Lyon / Hopital de la Croix Rousse
Nov 6, 2019
Corneal Neovascularization Trial in Petah Tikva (Aflibercept)
Terminated
- Corneal Neovascularization
- Aflibercept
-
Petah Tikva, IsraelRabin Medical Center
Sep 12, 2019
Wet Macular Degeneration Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)
Central Retinal Vein Occlusion Trial in United States (aflibercept, bevacizumab)
Completed
- Central Retinal Vein Occlusion
- aflibercept
- bevacizumab
-
Phoenix, Arizona
- +71 more
Jun 11, 2021
Diabetic Macular Edema Trial (micropulse laser, Aflibercept)
Completed
- Diabetic Macular Edema
- micropulse laser
- Aflibercept
- (no location specified)
Jul 8, 2019
Diabetic Macular Edema Trial in Toronto (aflibercept)
Completed
- Diabetic Macular Edema
- aflibercept
-
Toronto, Ontario, CanadaSt. Michael's Hospital Eye Clinic
Sep 17, 2019
Macular Edema, Retinal Artery Macroaneurysm Trial in Peoria (aflibercept)
Unknown status
- Macular Edema
- Retinal Artery Macroaneurysm
- aflibercept
-
Peoria, IllinoisIllinois Retina and Eye Associates
Aug 6, 2019
Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Worldwide (SCD411, Aflibercept)
Active, not recruiting
- Wet Age-related Macular Degeneration
- Neovascular Age-related Macular Degeneration
- SCD411
- Aflibercept
-
Beverly Hills, California
- +139 more
May 11, 2022
Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)
Completed
- Diabetic Macular Edema
- Aflibercept
- +2 more
-
Phoenix, Arizona
- +194 more
Apr 1, 2022
Diabetic Macular Edema Trial in Worldwide (Aflibercept, Faricimab, Sham Procedure)
Completed
- Diabetic Macular Edema
- Aflibercept
- +2 more
-
Mesa, Arizona
- +184 more
Apr 1, 2022
Idiopathic Choroidal Neovascularization Trial in Lyon (aflibercept)
Completed
- Idiopathic Choroidal Neovascularization
- aflibercept
-
Lyon, FranceHospices Civils de Lyon - Hôpital de la Croix-Rousse
Jul 22, 2019
Pseudoxanthoma Elasticum Trial in Bonn (Aflibercept)
Completed
- Pseudoxanthoma Elasticum
- Aflibercept
-
Bonn, GermanyDepartment of Ophthalmology, Universtiy of Bonn
May 5, 2019
Diabetic Macular Edema Trial in Houston, Katy, The Woodlands (Aflibercept, Focal Laser)
Completed
- Diabetic Macular Edema
- Aflibercept
- Focal Laser
-
Houston, Texas
- +2 more
May 15, 2019
Macular Edema, Branch Retinal Vein Occlusion Trial in Worldwide (Faricimab, Aflibercept, Sham Procedure)
Active, not recruiting
- Macular Edema
- Branch Retinal Vein Occlusion
- Faricimab
- +2 more
-
Phoenix, Arizona
- +151 more
Aug 4, 2022
Type 3 Choroidal Neovascularization Trial in Poitiers (Aflibercept)
Completed
- Type 3 Choroidal Neovascularization
- Aflibercept
-
Poitiers, France
- +1 more
Mar 7, 2019
Macular Edema, Diabetic Trial in Jinju, Busan, Daegu (aflibercept)
Unknown status
- Macular Edema, Diabetic
- aflibercept
-
Jinju, Gyeongsangnam-do, Korea, Republic of
- +7 more
Feb 27, 2019
Metastatic Colorectal Cancer Trial in Greece (5 Fluorouracil, Leucovorin, Irinotecan)
Unknown status
- Metastatic Colorectal Cancer
- 5 Fluorouracil
- +3 more
-
Heraklion, Crete, Greece
- +9 more
Feb 20, 2019
Neovascular Age-Related Macular Degeneration Trial in United States (GB-102, Aflibercept)
Completed
- Neovascular Age-Related Macular Degeneration
- GB-102
- Aflibercept
-
Gilbert, Arizona
- +7 more
Dec 18, 2019
Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Colon Trial in
Unknown status
- Mucinous Adenocarcinoma of the Colon
- +5 more
- aflibercept
- +7 more
-
Ann Arbor, Michigan
- +5 more
Mar 25, 2019
Eye Diseases, Optic Nerve Damage, Glaucoma Surgery Trial in Lublin (Aflibercept, Mitomycin)
Unknown status
- Eye Diseases
- +2 more
- Aflibercept
- Mitomycin
-
Lublin, Lubelskie, PolandMedical University of Lublin
Dec 4, 2018
Retinal Disease Trial (Aflibercept, Pranoprofen, Carotenoids)
Completed
- Retinal Disease
- Aflibercept
- +2 more
- (no location specified)
Oct 17, 2018